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A knowledge of the appearance and persistence
of VDRL, RPCF, and TPI antibody during the
course and treatment of syphilitic infection has
become increasingly important with the devel-
opment and general acceptance of the "triple
test plan" for the serologic diagnosis of syphilis
(1). The plan is designed primarily to aid the
physician in differentiating biologic false positive(BFP) reactors from latent syphilitics. The
VDRL test is used as a preliminary screening
procedure for patients with no history or clinical
manifestations of syphilitic infection. A non-re-
active result is accepted as evidence for the absence
of syphilis while reactive or weakly reactive sera
are subjected to the RPCF test. A corroborative
reactive or weakly reactive RPCF result is con-
sidered evidence for past or present infection
with Trepcrnema pallidum, while a non-reactive
result necessitates the performance of a TPI test.
If the TPI test is reactive, past or present infec-
tion is indicated; a non-reactive result signifies a
BFP reaction.
One of the major problems confronting the
authors of the plan has been the reluctance of
some investigators to accept a reactive or weakly
reactive RPCF result as conclusive evidence for
past or present syphilitic infection, despite the
fact that preliminary observations on sera from
patients with known syphilis have indicated the
high degree of specificity of the test (2, 3). Inas-
much as the TPI test is generally considered to be
highly accurate during the latent stage of syphilis,
the validity of the RPCF results was questioned
when studies in this laboratory demonstrated that
8.5 per cent, or 50 of 588 patients with no defini-
tive history or clinical manifestations of syphilis
had reactive or weakly reactive RPCF and non-
reactive TPI tests (4). The importance of assess-
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ing the accuracy of the RPCF test in such cases
became apparent in view of the fact that serologic
reactions are the only means available to the
physician for diagnosis. Convincing evidence that
serologic discrepancies of this nature could be
related to past infection with T. pallidum was
provided by studies in which three patients ade-
quately treated with penicillin during the early
stages of the disease showed reactive or weakly
reactive RPCF and VDRL tests and non-reactive
TPI results (2). Presumably, at the time of
therapy, RPCF antibody and reagin had either
reached a significantly higher titer than TPI
antibody or had formed prior to the appearance
of the latter.
The interesting possibility that similar findings
may occur in treated latency led to the present
study to determine the relative fate of these three
antibodies in rabbits following adequate penicillin
therapy administered during the latent stage. In
addition, theft appearance following onset of
infection and their persistence up to the time of
treatment was determined.
METHODS AND MATERIALS
Fifteen adult, male, Dutch rabbits with non-
reactive VDRL, RPCF, and TPI tests were se-
lected and housed in individual cages at a tempera-
ture of 68° to 70° F. They were inoculated intra-
testicularly with a total of 4.2 X 10° virulent 7'.
paltidum, Nichols strain, prepared as previously
described. (5). Each animal developed dark field
positive lesions, and the time of their development
and subsequent healing noted. Twenty-four weeks
after infection, the animals were injected intra-
muscularly with a single curative dose of 1.2 mil-
lion units of benzathine penicillin G (Bicillin).
Blood samples for both qualitative and quanti-
tative serologic tests were obtained by cardiac
puncture at varying intervals during the course of
the untreated disease, immediately prior to peni-
cillin therapy, and for 48 weeks thereafter. At the
final bleeding, 5 of the 15 rabbits had succumbed.
Following removal of the serum, the samples were
stored at —20° C until tested.
The VDRL slide flocculation test was performed
as described in the Manual of Serologic Tests for
Syphilis. (6) The TPI test was carried out accord-
ing to the method of Nelson and Mayer (7) with
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The individual VDRL, RPCF, and TPI antibody responses during the course and greagmeng
of experimental syphilis in 15 rabbit8
Weeks after Infection Weeks after Treatment
Rabbit Test — ________________
2 4 6 8 12 16 20 24 4 16 28 48
1 VDRL 4 16 16 4 1 1 NR NR NR
RPCF 160 640 320 160 80 40 40 40 20
TPI <10 40 20 80 80 40 40 10 20
2 VI)RL 4 32 16 4 2 1 NR NR —
RPCF 80 320 320 320 160 80 80 80 —
TPI NR 10 20 80 80 20 10 10 —
3 VDRL 2 32 16 1 1 — — — —
RPCF 320 640 160 160 160 — — — —
TPI NR 10 40 80 80 — — — —
4 VDRL NR 4 2 1 1 — — — —
RPCF 80 160 160 160 160 — — — —
TPI NR <10 10 10 20 — — — —
5 VDRL 4 32 16 2 1 NR NR NR NR
RPCF 160 320 320 160 160 80 80 80 40
TPI NR 10 10 10 10 10 NR 10 <10
6 VDRL NR 32 16 4 2 1 — — —
RPCF 160 640 640 320 320 160 — — —
TPI <10 10 20 10 20 El 10 — — —
7 VDRL NR 32 8 1 1 z NR NR NR —
RPCF 80 640 320 160 160 40 20 20 —
TPI NR 10 <10 10 <10 10 NR NR —
8 VDRL 8 8 4 2 1 1 NR — NR
RPCF 40 40 40 40 80 80 40 — 40
TPI NR NR NR 10 20 10 10 — <10
9 VDRL 32 32 4 2 1 NR NR NR NR
RPCF 320 320 640 160 160 80 80 40 40
TPI 10 10 20 20 20 10 NR 10 NR
10 VDRL 32 16 4 2 1 0 1 NR NR NR
RPCF 320 320 320 320 320 320 160 80 80
TPI 10 10 20 40 40 10 10 10 NR
11 VDRL 32 16 4 2 1 1 NR NR NR
RPCF 320 320 320 160 160 160 160 160 160
TPI 20 20 40 40 40 10 10 10 10
12 VDRL 16 4 2 2 1 NR NR NR NR
RPCF 160 160 80 160 160 160 80 80 40
TPI <10 <10 10 10 10 NR NR 10 <10
13 VDRL 16 4 2 1 1 NR NR NR NR
RPCF 320 160 160 320 320 160 80 80 40
TPI 10 10 10 20 40 20 10 10 <10
14 VDRL 32 16 4 2 2 1 1 <1 NR
RPCF 320 160 80 160 160 160 40 20 20
TPI <10 10 20 20 20 10 10 NR NR
15 VDRL 16 8 2 1 1 NR NR NR NR
RPCF 160 80 160 160 160 160 80 80 80
TPI <10 10 10 20 40 20 10 NR <10
* VDRL expressed in dils.
RPCF and TPI expressed as reciprocal of final dilution.
— Not tested.
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modification as described by Magnuson and
Thompson, (8) Thompson and Magnuson, (9) and
Boak and Miller. (10) The RPCF test, utilizing
Reiter protein antigen, kindly supplied by Or-
ganon, Inc., was performed according to the
method described by Portnoy and Magnuson (11)
for the TPCF test employing the one-fifth volume
Kolmer technic.
RESULTS
As shown in the Table, each of the 8 rabbits
tested two weeks after infection had developed
RPCF antibodies, the titers ranging from 1:40 to
1:320; three of the animals exhibited non-reactive
VDRL tests, six had still failed to develop TPI
antibody, and four showed reactive VDRL and
non-reactive TPI tests. During the course of the
disease, darkfield positive lesions appeared in
each of the 15 infected rabbits following an
average incubation period of 3.5 weeks. At this
time, reagin (VDRL) levels had reached mat-
mum while both RPCF and TPI antibody were
increasing (Figure 1). Complete, spontaneous
healing of the lesions, initiating the latent stage,
occurred in an average time of 5.8 weeks after
their development or 9.3 weeks following infec-
tion.
As latency continued, average reagin titers
declined steadily both prior to and following
curative therapy. By the sixteenth week after
treatment, 11 of the 12 rabbits had shown VDRL
non-reactivity (Table). It is apparent that this
decline would undoubtedly have occurred even
in the absence of treatment.
The average RPCF antibody titer reached a-
peak level 2.5 weeks after the appearance of pri-
mary lesions and had declined at the onset of
latency to a titer which persisted at the same
approximate level up to the time of penicillin
therapy. Although RPCF antibody decreased
during the period following treatment, significant
levels were detectable in each of the surviving
10 rabbits 48 weeks after therapy (Table).
Immobilizing antibody continued to increase
during the healing process, reached an average
peak titer 16 weeks after infection, and remained
at this approximate level until treatment was
begun, following which time the titers steadily
declined (Figure 1). It is of particular interest to
note that 7 of the 13 animals tested exhibited
non-reactive TPI tests at some time during the
48 weeks following therapy. In each instance, the
RPCF test was reactive while reagin was de-
monstrable in only one instance (Table).
DIsCUssION
The demonstration that RPCF antibody may
appear before reagin and TPI antibody during the
course of experimental syphilis in the rabbit is in
agreement with similar observations by Darda-
noni. (12) Although the effects on antibody levels
of adequate treatment during this early stage of
the disease were not determined, Bekker and
Onvlee (13) have shown that rabbits given cura-
tive penicillin therapy 3 weeks after orchitis
development may convert from TPI reactive to
non-reactive prior to the disappearance of RPCF
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antibody. These findings are in agreement with
the observations of Miller, Boak, and Carpenter
(2) in which three patients treated during the
early stages of the disease exhibited reactive
RPCF and non-reactive TPI tests.
The present investigation indicates that the ad-
ministration of adequate penicillin to infected rab-
bits 15 weeks after development of the latent stage
may result in a reversal in TPI reactivity from 16
to 48 weeks after therapy while RPCF antibody
remains at measurable levels. Although these data
tend to support the hypothesis that patients
treated during the latent stage of syphilitic in-
fection may exhibit reactive RPCF and non-
reactive TPI tests, caution must be exercised in
relating these observations on rabbits to humans.
Nelson (14) has established the fact that the
administration of curative penicillin therapy to
patients during the latent stage of the disease
when TPI antibody levels are maximal results in
no appreciable effect on the titer. This is in con-
trast to the present study in which immobilizing
antibody was at relatively low titers at the time of
therapy and conversion to non-reactivity oc-
curred. Further, the more rapid disappearance of
reagin compared to TPI antibody in rabbits dur-
ing this investigation tends to preclude the theory
that a reactive VDRL may exist concomitantly
with a reactive RPCF and non-reactive TPI test
in the presence of treated syphilitic infection.
Yet there is unequivocal evidence that such
reactions may occur in patients with treated pri-
mary or secondary syphilis (2), thereby implying
the persistence of reagin if treatment were delayed
until latency. These differences in antibody levels
might well be attributed to the size and virulence
of the infecting inoculum, the route of infection,
the response of the host, or other factors as yet
unknown. It would, therefore, appear reasonable
that qualitative differences in antibody titers in
the rabbit foilowing infection and treatment ob-
served during this study might also occur in man.
These conclusions are in no way intended to
detract from the value of the TPI test in differen-
tiating latent syphilis from BFP reactions. The
greatest majority of diagnostic problem cases
(82.5 to 82.7 per cent in our study) (4) show
agreement of TPI and RPCF results. However,
the tendency to question the validity of a reactive
RPCF test while accepting TPI reactivity as
accurate is not consistent with the available
evidence. Convincing clinical and epidemiologic
data are available to support the acceptance of
both reactions as accurate (2, 3, 7, 15, 16, 17).
Further, it appears reasonable that the wide-
spread use of antibiotics may have an appreciable
effect upon both TPI and RPCF antibody when
administered early enough during the course of
the infection. It is of particular interest to note
that even in untreated latent syphilis, non-reac-
tive TPI tests have been reported (18).Acceptance
of the reactive or weakly reactive RPCF test as
evidence for present or past infection with T.
pallidum according to "triple test plan" recom-
mendations would contribute immeasurably to
maximum detection of the disease.
SUMMARY
The VDRL, RPCF, and TPI titers of 15 rab-
bits were determined foilowing intratesticular
infection with 4.2 X 106 virulent Treponema pal-
lidum, Nichols strain, and treatment 24 weeks
later with 1.2 million units of benzathine peni-
cillin G (Biciilin).
Two weeks after infection, each of 8 rabbits
tested had developed RPCF antibodies. Three
of these animals exhibited non-reactive VDRL
tests, 6 had stiil failed to develop TPI antibody,
and 4 showed reactive VDRL and non-reactive
TPI tests.
Seven of 13 animals tested at varying intervals
after peniciilin therapy exhibited non-reactive
TPI and reactive RPCF tests at some time during
the 48 weeks following treatment. Reagin, as
measured by the VDRL procedure, was demon-
strable in only one instance.
The results suggest that non-reactive TPI and
reactive or weakly reactive RPCF tests may occur
in treated latent human syphilis. The accuracy
of its reactivity confirms the value of the RPCF
test when employed in the "triple test plan" for
serologic diagnosis.
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